Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG

The only currently available vaccine against tuberculosis (TB) is Mycobacterium bovis Bacille Calmette-Guerin (BCG), which has inconsistent efficacy to protect against the disease in adults. M. tuberculosis (MTB) cell wall components have been implicated in the pathogenicity of TB and therefore have...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Fátima, Tirado, Yanely, Puig, Alina, Borrero, Reinier, Reyes, Giselle, Fernández, Sonsire, Pérez, José Luis, Kadir, Ramlah, Zayas, Caridad, Norazmi, Mohd Nor, Sarmiento, María E, Acosta, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582439/
https://www.ncbi.nlm.nih.gov/pubmed/23458692
http://dx.doi.org/10.1186/1471-2172-14-S1-S7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582439/
https://www.ncbi.nlm.nih.gov/pubmed/23458692
http://dx.doi.org/10.1186/1471-2172-14-S1-S7

Ejemplares similares